IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

In8bio Inc

CUSIP: 45674E109 | 59 institutional holders

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ABios Capital Management, LP
with Cavu Advisors, LLC, Cavu Management, LP, Kreis Leslie W., +13 more
391,3574.0%Newly reportedDec 22, 2025286,664 sh (Sep 30, 2025)

Institutional Holders — Q3 2025

Bios Capital Management, LP286,664
0.7% of portfolio›$622.1K
StyleTurnoverLocationFiled
Bios Capital Management, LP
286,664$622.1K0.7%Deep ValueVery LowFort Worth, TX2025-11-12
13D/A
Bios Capital Management, LP
391,357
4.0% of class · Dec 22, 2025Newly reported
with Cavu Advisors, LLC, Cavu Management, LP, Kreis Leslie W., +13 more
286,664 sh (Sep 30, 2025)